
Newly designed microneedle patch helps people with diabetes to enable them to monitor their glucose levels throughout the day in a 'pain-free' manner.
Continuous monitoring is a way to safely and reliably lower blood glucose - giving the user a full picture of their glucose levels throughout the day and helping them avoid severe hypoglycemia.
Advertisement
‘Novel microneedle patch which is designed to monitor blood glucose levels is 50 times smaller than the needles used in today’s continuous glucose monitoring systems.
’
Read More..
Tweet it Now
Read More..
But the currently used continuous glucose monitoring systems (known as CGMS) are uncomfortable since they require a minimum 7mm needle inserted into the skin. Owing to their size, they take measurements in the fat tissue - not an ideal location.
However, the new device, developed by researchers at KTH Royal Institute of Technology in Sweden, is 50 times smaller.
When applied to a human participant's forearm, the combination of the patch and an extremely miniaturized three-electrode enzymatic sensor was found capable of correctly and dynamically tracking blood glucose levels over time, with a delay of about 10 minutes.
"Our solution is painless to the user. We measure directly in the skin, and there are no nerve receptors that detect pain - just a fine mesh of very tiny blood vessels," Federico Ribe, a doctoral student at the institute, said.
Unlike commercially available CGMS which measure the subcutaneous fat tissue, the new device measures within the skin less than 1mm deep, Ribet said.
This would offer an alternative to pricking one's fingers several times a day to take a blood test, and the frequency of finger prick tests could be reduced with a glucose monitoring system, he noted.
The team has successfully tested the prototype of a microneedle patch on a human participant, and the completion of a system for clinical tests is now underway.
Source: IANS
When applied to a human participant's forearm, the combination of the patch and an extremely miniaturized three-electrode enzymatic sensor was found capable of correctly and dynamically tracking blood glucose levels over time, with a delay of about 10 minutes.
Advertisement
"Our solution is painless to the user. We measure directly in the skin, and there are no nerve receptors that detect pain - just a fine mesh of very tiny blood vessels," Federico Ribe, a doctoral student at the institute, said.
Unlike commercially available CGMS which measure the subcutaneous fat tissue, the new device measures within the skin less than 1mm deep, Ribet said.
This would offer an alternative to pricking one's fingers several times a day to take a blood test, and the frequency of finger prick tests could be reduced with a glucose monitoring system, he noted.
The team has successfully tested the prototype of a microneedle patch on a human participant, and the completion of a system for clinical tests is now underway.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News

Researchers have shown that gestational diabetes can be identified as early as the first trimester of pregnancy, which is typically months before it is typically diagnosed.

A new smartphone app or support tool developed helps improve mental health in individuals with type 1 diabetes.

Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.

Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.

New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.